Find and Pitch Jounalists, Get Your Story Covered

Tags: amazon bob chapek crunchyroll disney epic games

	Profile	Recent Articles on Subject
1	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Up and down the ladder: The latest comings and goings - 5 days ago STAT+: Up and down the ladder: The latest comings and goings - about 2 months ago STAT+: Up and down the ladder: The latest comings and goings - 3 months ago STAT+: Up and down the ladder: The latest comings and goings - 4 months ago STAT+: Up and down the ladder: The latest comings and goings - 4 months ago STAT+: Up and down the ladder: The latest comings and goings - 4 months ago STAT+: Pharmalittle: We’re reading about Trump and tariff worries, PBM rules in New York, and more - 4 months ago STAT+: Up and down the ladder: The latest comings and goings - 5 months ago STAT+: Up and down the ladder: The latest comings and goings - 5 months ago STAT+: Up and down the ladder: The latest comings and goings - 5 months ago STAT+: Pharmalittle: We’re reading about ballooning 340B drug sales, Catalent reassuring customers, and more - 5 months ago STAT+: Up and down the ladder: The latest comings and goings - 6 months ago STAT+: Up and down the ladder: The latest comings and goings - 6 months ago STAT+: Up and down the ladder: The latest comings and goings - 7 months ago STAT+: Up and down the ladder: The latest comings and goings - 7 months ago STAT+: Up and down the ladder: The latest comings and goings - 8 months ago STAT+: Up and down the ladder: The latest comings and goings - 8 months ago STAT+: A Senate bill was touted as a cure for ‘patent thickets.’ Some say the drug industry watered it down - 9 months ago STAT+: Up and down the ladder: The latest comings and goings - 9 months ago STAT+: Up and down the ladder: The latest comings and goings - 9 months ago STAT+: Up and down the ladder: The latest comings and goings - 11 months ago STAT+: Up and down the ladder: The latest comings and goings - 12 months ago STAT+: Pharmalittle: We’re reading about biotech startups, Pfizer’s RSV vaccine, and more - 12 months ago STAT+: Up and down the ladder: The latest comings and goings - 12 months ago STAT+: Up and down the ladder: The latest comings and goings - about 1 year ago STAT+: Up and down the ladder: The latest comings and goings - over 1 year ago STAT+: Up and down the ladder: The latest comings and goings - over 1 year ago STAT+: Up and down the ladder: The latest comings and goings - over 1 year ago STAT+: Up and down the ladder: The latest comings and goings - over 1 year ago
2	Brittany Trang STAT News Health care business reporter. PhD. Indie rock fan. health carebusiness reporting	STAT+: Epic, CHAI, and others weigh in on demand for AI at HIMSS25 - 28 days ago STAT+: AI agents, bursting the AI drug hype bubble, and how health & medicine uses AI - about 2 months ago Morning Rounds: A STAT crossword, Atul Gawande, and hearing music with hearing aids - 6 months ago STAT+: 3 health policies states are taking on in 2024 - over 1 year ago
3	Helen Branswell STAT News Frontiers of health & medicine reporting. healthmedicinejournalism	STAT+: Drug inspectors, AI experts, maternal health workers: Trump’s health agency cuts are far-reaching - about 1 month ago
4	Rick Berke STAT News Co-founder & executive editor. Longtime reporter. Boston, Massachusetts newsediting	STAT wins third Polk Award for Health Care’s Colossus series - about 1 month ago STAT turns 8: A letter from the executive editor - over 1 year ago
5	Matthew Herper STAT News Writes at STAT. Biology's century. Undisclosed biologydatajournalism	STAT+: How Trump’s ‘fear factor’ is already reshaping American science - about 2 months ago STAT+: How a tweet about a gene discovered long ago led to a $190 million startup and, maybe, hope for heart disease - 10 months ago
6	Natalie Schwartz Education Dive Editor at Higher Ed Dive. Ellicott City, Maryland editinghigher education	This week in 5 numbers: Court temporarily blocks NIH funding cuts - about 2 months ago
7	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Biotech is in a dark place - about 2 months ago STAT+: Biotech companies detail emerging efforts to ease ‘conditioning’ before genetic treatments - 4 months ago STAT+: The state of biotech M&A 2024 - 4 months ago STAT+: On Andrew Left and the government’s fraud case - 8 months ago STAT+: The inside story of Enhertu’s pan-tumor approval - 12 months ago STAT+: Weed for weight loss, and more from Biotech Land - 12 months ago STAT+: A contrarian view on Viking Therapeutics, biotech’s hottest obesity stock - about 1 year ago STAT+: The biotech scorecard for the first quarter: 17 stock-moving events to watch - over 1 year ago STAT Virtual Event \| Cancer’s Breakthrough Engine - over 1 year ago Listen: Live from the 2023 STAT Summit - over 1 year ago
8	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: Is Trump’s new order a reprieve for biotech? - about 2 months ago STAT+: 3 trends to watch in biotech in 2025 - 3 months ago
9	Theresa Gaffney STAT News Audio producer, health reporter. Boston audio productionhealth reporting	Salt substitutes as a way to lower risk of death, stroke - about 2 months ago A STAT Investigation: Pain, loss, and coercive care - 5 months ago Morning Rounds: Highlights from the STAT Summit - 6 months ago
10	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Denali Therapeutics spinout raises $200M as neuro company resets - 3 months ago STAT Virtual Event \| 2024 JPM Recap, Live! - about 1 year ago Listen: Live from the 2023 STAT Summit - over 1 year ago

Journalists covering STAT News